These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25693006)

  • 1. Genetics of Opisthorchis viverrini-related cholangiocarcinoma.
    Jusakul A; Kongpetch S; Teh BT
    Curr Opin Gastroenterol; 2015 May; 31(3):258-63. PubMed ID: 25693006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic and transcriptional alterations of cholangiocarcinoma.
    Ito T; Sakurai-Yageta M; Goto A; Pairojkul C; Yongvanit P; Murakami Y
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):380-7. PubMed ID: 24532422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exome sequencing of liver fluke-associated cholangiocarcinoma.
    Ong CK; Subimerb C; Pairojkul C; Wongkham S; Cutcutache I; Yu W; McPherson JR; Allen GE; Ng CC; Wong BH; Myint SS; Rajasegaran V; Heng HL; Gan A; Zang ZJ; Wu Y; Wu J; Lee MH; Huang D; Ong P; Chan-on W; Cao Y; Qian CN; Lim KH; Ooi A; Dykema K; Furge K; Kukongviriyapan V; Sripa B; Wongkham C; Yongvanit P; Futreal PA; Bhudhisawasdi V; Rozen S; Tan P; Teh BT
    Nat Genet; 2012 May; 44(6):690-3. PubMed ID: 22561520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Biomarkers and the Wnt/β-Catenin Pathway in Opisthorchis viverrini-associated Cholangiocarcinoma: A Scoping Review on Therapeutic Opportunities.
    Kafle A; Suttiprapa S; Muhammad M; Tenorio JCB; Mahato RK; Sahimin N; Loong SK
    PLoS Negl Trop Dis; 2024 Sep; 18(9):e0012477. PubMed ID: 39236081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered gene expression in Opisthorchis viverrini-associated cholangiocarcinoma in hamster model.
    Loilome W; Yongvanit P; Wongkham C; Tepsiri N; Sripa B; Sithithaworn P; Hanai S; Miwa M
    Mol Carcinog; 2006 May; 45(5):279-87. PubMed ID: 16550611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of KRAS and TP53 in a minor proportion of Opisthorchis viverrini-associated cholangiocarcinomas in a hamster model.
    Tangkawattana S; Kaewkes S; Pairojkul C; Tangkawattana P; Sripa B
    Asian Pac J Cancer Prev; 2008; 9(1):101-6. PubMed ID: 18439086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MTHFR polymorphisms and Opisthorchis viverrini infection: a relationship with increased susceptibility to cholangiocarcinoma in Thailand.
    Songserm N; Promthet S; Sithithaworn P; Pientong C; Ekalaksananan T; Chopjitt P; Parkin DM
    Asian Pac J Cancer Prev; 2011; 12(5):1341-5. PubMed ID: 21875294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke
    Surapaitoon A; Suttiprapa S; Mairiang E; Khuntikeo N; Pairojkul C; Bethony J; Brindley PJ; Sripa B
    Korean J Parasitol; 2017 Jun; 55(3):295-304. PubMed ID: 28719954
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways.
    Kongpetch S; Jusakul A; Ong CK; Lim WK; Rozen SG; Tan P; Teh BT
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):233-44. PubMed ID: 25966424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma.
    Jinawath N; Chamgramol Y; Furukawa Y; Obama K; Tsunoda T; Sripa B; Pairojkul C; Nakamura Y
    Hepatology; 2006 Oct; 44(4):1025-38. PubMed ID: 17006947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator.
    Silakit R; Loilome W; Yongvanit P; Chusorn P; Techasen A; Boonmars T; Khuntikeo N; Chamadol N; Pairojkul C; Namwat N
    J Hepatobiliary Pancreat Sci; 2014 Dec; 21(12):864-72. PubMed ID: 25131257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers.
    Chan-On W; Nairismägi ML; Ong CK; Lim WK; Dima S; Pairojkul C; Lim KH; McPherson JR; Cutcutache I; Heng HL; Ooi L; Chung A; Chow P; Cheow PC; Lee SY; Choo SP; Tan IB; Duda D; Nastase A; Myint SS; Wong BH; Gan A; Rajasegaran V; Ng CC; Nagarajan S; Jusakul A; Zhang S; Vohra P; Yu W; Huang D; Sithithaworn P; Yongvanit P; Wongkham S; Khuntikeo N; Bhudhisawasdi V; Popescu I; Rozen SG; Tan P; Teh BT
    Nat Genet; 2013 Dec; 45(12):1474-8. PubMed ID: 24185513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Potential Biomarkers for
    Aksorn N; Roytrakul S; Kittisenachai S; Leelawat K; Chanvorachote P; Topanurak S; Hamano S; Lek-Uthai U
    In Vivo; 2018; 32(4):871-878. PubMed ID: 29936472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: a potential molecular marker for tumor metastasis.
    Loilome W; Wechagama P; Namwat N; Jusakul A; Sripa B; Miwa M; Kuver R; Yongvanit P
    Parasitol Int; 2012 Mar; 61(1):136-9. PubMed ID: 21763455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma.
    Yongvanit P; Pinlaor S; Loilome W
    J Hepatobiliary Pancreat Sci; 2014 May; 21(5):309-15. PubMed ID: 24408859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma.
    Boonjaraspinyo S; Wu Z; Boonmars T; Kaewkes S; Loilome W; Sithithaworn P; Nagano I; Takahashi Y; Yongvanit P; Bhudhisawasdi V
    Parasitol Int; 2012 Mar; 61(1):145-50. PubMed ID: 21777692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholangiocarcinoma in experimental hamsters with long-standing Opisthorchis viverrini infection.
    Songserm N; Prasongwattana J; Sithithaworn P; Sripa B; Pipitkool V
    Asian Pac J Cancer Prev; 2009; 10(2):299-302. PubMed ID: 19537899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis.
    Sawanyawisuth K; Silsirivanit A; Kunlabut K; Tantapotinan N; Vaeteewoottacharn K; Wongkham S
    Parasitol Int; 2012 Mar; 61(1):151-4. PubMed ID: 21784171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opisthorchis viverrini infection activates the PI3K/ AKT/PTEN and Wnt/β-catenin signaling pathways in a Cholangiocarcinogenesis model.
    Yothaisong S; Thanee M; Namwat N; Yongvanit P; Boonmars T; Puapairoj A; Loilome W
    Asian Pac J Cancer Prev; 2014; 15(23):10463-8. PubMed ID: 25556493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wound healing and cancer progression in Opisthorchis viverrini associated cholangiocarcinoma.
    Botelho MC; Alves H; Richter J
    Parasitol Res; 2016 Jul; 115(7):2913-4. PubMed ID: 27130317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.